Amgen, Actavis Close On Billion-Dollar Pharma Deals

Law360, New York (October 1, 2013, 2:06 PM EDT) -- Amgen Inc. has successfully closed its $10.4 billion acquisition of Onyx Pharmaceuticals Inc., and Warner Chilcott PLC and Actavis Inc. have completed their $8.5 billion merger, wrapping up on Tuesday two of the year's biggest pharmaceutical deals.

Amgen finalized the deal — its largest ever — just hours after closing the $125-per-share tender offer for Onyx, thanks to a new quick-close Delaware law. About 78.5 percent of shares were tendered, well above the simple majority needed to seal the deal under the new statute known as...
To view the full article, register now.